Papworth invests in SonoSite's M-Turbo(R) for cardiac anaesthesia and intensive care

Papworth Hospital, Cambridgeshire has invested in SonoSite's M-Turbo® point-of-care ultrasound system. End Quote

(1888PressRelease) May 18, 2012 - Papworth Hospital, Cambridgeshire, the UK's largest specialist cardiothoracic hospital and main heart and lung transplant centre, has invested in SonoSite's M-Turbo® point-of-care ultrasound system for its cardiac intensive care unit (ICU). Dr Kamen Valchanov, consultant anaesthetist, explained: "Papworth is a big cardiac centre with a busy intensive care unit. As our use of ultrasound increased, we found we needed additional equipment and we recently purchased an M-Turbo. We mainly use the system in ICU for diagnosis of cardiac and thoracic pathology, and for performing ultrasound-guided procedures. For the majority of the time the M-Turbo is used for venous access procedures, but we are using it more and more for nerve blocks in the operating theatres and the pain clinic."

"Ultrasound has become important in pretty much all areas of medicine, and there are many situations where portable ultrasound systems are considered essential. The portability of the M-Turbo is good, and the image quality is much better than our previous instrument. Our old system was only good enough to allow us to perform vascular access procedures, but the M-Turbo has much better resolution, allowing us to do much more. It gives us the capability to export and store images, which is important, and is very intuitive, requiring minimal training. We also have an excellent relationship with the team at SonoSite, who provide us with good support."

For more information about SonoSite products, please contact:
SonoSite Ltd,
Alexander House, 40A Wilbury Way, Hitchin SG4 0AP

T +44 (0)1462 444 800, F +44 (0)1462 444 801
ukresponse ( @ ) sonosite dot com www dot sonosite dot com

About SonoSite
SonoSite, Inc. (www.sonosite.com), a subsidiary of FUJIFILM, is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

SonoSite, Ltd., a wholly owned subsidiary of SonoSite, Inc. based in Hitchin, Hertfordshire, oversees a direct sales distribution network in the UK and provides sales and marketing support for SonoSite's European offices.

###

space

Other Related Press Releases

Papworth invests in SonoSite's M-Turbo(R) for cardiac anaesthesia and intensive care by Sonosite